Related Experiment Video
Updated: May 12, 2026
11:47
Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
Published on: March 4, 2022
Microalbuminuria in chronic obstructive pulmonary disease
Emel Bulcun1, Mehmet Ekici, Aydanur Ekici
1Department of Pulmonary Medicine, University of Kirikkale, Faculty of Medicine, Kirikkale, Turkey. emelbulcun@hotmail.com
COPD
|April 4, 2013
Summary
Microalbuminuria is more common in COPD patients and linked to disease severity and hypoxemia. Regular screening for microalbuminuria in severe COPD is recommended to assess cardiovascular risk.
Area of Science:
- Pulmonary Medicine
- Nephrology
- Cardiovascular Medicine
Background:
- Microalbuminuria is a significant risk factor for cardiovascular diseases.
- Hypoxemia in Chronic Obstructive Pulmonary Disease (COPD) may lead to microalbuminuria.
Purpose of the Study:
- To investigate the prevalence of microalbuminuria in COPD patients.
- To examine the relationship between microalbuminuria and clinical/physiological parameters in COPD.
Main Methods:
- Included 66 COPD patients and 40 healthy smokers.
- Calculated urinary albumin-to-creatinine ratio (UACR) and defined microalbuminuria thresholds.
- Assessed disease severity using the Multidimensional COPD Severity Index (MCIRS) and BODE index.
Main Results:
- Microalbuminuria and higher UACR were observed more frequently in COPD patients.
- UACR showed inverse correlations with PaO2, FEV1%, FVC% and positive correlation with BODE index.
- Microalbuminuria presence was significantly associated with lower PaO2 and higher BODE index and MCIRS score.
Conclusions:
- Microalbuminuria prevalence in COPD is associated with disease severity and hypoxemia.
- Regular monitoring of microalbuminuria in severe COPD patients is crucial for cardiovascular risk assessment.
More Related Videos
Related Concept Videos
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.